Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative AKRO - Akero Therapeutics, Inc.
31.1 M
LAST VALUE
27.46%
2 YEAR CAGR
74.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR